Search Results - "Solheim, Joyce C."

Refine Results
  1. 1

    Cancer-associated mucins: role in immune modulation and metastasis by Bhatia, Rakesh, Gautam, Shailendra K., Cannon, Andrew, Thompson, Christopher, Hall, Bradley R., Aithal, Abhijit, Banerjee, Kasturi, Jain, Maneesh, Solheim, Joyce C., Kumar, Sushil, Batra, Surinder K.

    Published in Cancer and metastasis reviews (01-06-2019)
    “…Mucins (MUC) protect epithelial barriers from environmental insult to maintain homeostasis. However, their aberrant overexpression and glycosylation in various…”
    Get full text
    Journal Article
  2. 2

    Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells by Larson, Alaina C, Knoche, Shelby M, Brumfield, Gabrielle L, Doty, Kenadie R, Gephart, Benjamin D, Moore-Saufley, Promise R, Solheim, Joyce C

    “…Pancreatic cancer is a lethal disease, harboring a five-year overall survival rate of only 13%. Current treatment approaches thus require modulation, with…”
    Get full text
    Journal Article
  3. 3

    The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer by Larson, Alaina C., Doty, Kenadie R., Solheim, Joyce C.

    Published in Cancer medicine (Malden, MA) (01-05-2024)
    “…Although the development of immunotherapies has been revolutionary in the treatment of several cancers, many cancer types remain unresponsive to immune‐based…”
    Get full text
    Journal Article
  4. 4

    The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer by Knoche, Shelby M, Brumfield, Gabrielle L, Goetz, Benjamin T, Sliker, Bailee H, Larson, Alaina C, Olson, Madeline T, Poelaert, Brittany J, Bavari, Audrey, Yan, Ying, Black, Jennifer D, Solheim, Joyce C

    Published in PloS one (20-09-2022)
    “…The histone deacetylase (HDAC) inhibitor vorinostat, used with gemcitabine and other therapies, has been effective in treatment of experimental models of…”
    Get full text
    Journal Article
  5. 5

    Amyloid precursor protein and amyloid precursor-like protein 2 in cancer by Pandey, Poomy, Sliker, Bailee, Peters, Haley L, Tuli, Amit, Herskovitz, Jonathan, Smits, Kaitlin, Purohit, Abhilasha, Singh, Rakesh K, Dong, Jixin, Batra, Surinder K, Coulter, Donald W, Solheim, Joyce C

    Published in Oncotarget (12-04-2016)
    “…Amyloid precursor protein (APP) and its family members amyloid precursor-like protein 1 (APLP1) and amyloid precursor-like protein 2 (APLP2) are type 1…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Productive association between MHC class I and tapasin requires the tapasin transmembrane/cytosolic region and the tapasin C-terminal Ig-like domain by Simone, Laura C., Georgesen, Corey J., Simone, Peter D., Wang, Xiaojian, Solheim, Joyce C.

    Published in Molecular immunology (01-01-2012)
    “…► Tapasin Δ334–342, but not soluble tapasin, facilitates murine MHC class I surface expression. ► Soluble tapasin has a dominant negative effect over tapasin…”
    Get full text
    Journal Article
  8. 8

    Mechanism for Amyloid Precursor-like Protein 2 Enhancement of Major Histocompatibility Complex Class I Molecule Degradation by Tuli, Amit, Sharma, Mahak, Capek, Haley L., Naslavsky, Naava, Caplan, Steve, Solheim, Joyce C.

    Published in The Journal of biological chemistry (04-12-2009)
    “…Earlier studies have demonstrated interaction of the murine major histocompatibility complex (MHC) class I molecule Kd with amyloid precursor-like protein 2…”
    Get full text
    Journal Article
  9. 9

    Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desert by Li, Xiaoqi, Gulati, Mansi, Larson, Alaina C., Solheim, Joyce C., Jain, Maneesh, Kumar, Sushil, Batra, Surinder K.

    Published in Seminars in cancer biology (01-11-2022)
    “…Pancreatic cancer (PC) has exceptionally high mortality due to ineffective treatment strategies. Immunotherapy, which mobilizes the immune system to fight…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Emerging trends in the immunotherapy of pancreatic cancer by Banerjee, Kasturi, Kumar, Sushil, Ross, Kathleen A., Gautam, Shailendra, Poelaert, Brittany, Nasser, Mohd Wasim, Aithal, Abhijit, Bhatia, Rakesh, Wannemuehler, Michael J., Narasimhan, Balaji, Solheim, Joyce C., Batra, Surinder K., Jain, Maneesh

    Published in Cancer letters (28-03-2018)
    “…Pancreatic cancer (PC) is the fourth leading cause of cancer-related deaths in the U.S., claiming approximately 43,000 lives every year. Much like other solid…”
    Get full text
    Journal Article
  12. 12

    Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β by Liu, Luman, Kshirsagar, Prakash, Christiansen, John, Gautam, Shailendra K., Aithal, Abhijit, Gulati, Mansi, Kumar, Sushil, Solheim, Joyce C., Batra, Surinder K., Jain, Maneesh, Wannemuehler, Michael J., Narasimhan, Balaji

    “…Pancreatic cancer (PC) is one of the most lethal malignancies and represents an increasing and challenging threat, especially with an aging population. The…”
    Get full text
    Journal Article
  13. 13

    The role of tumor heterogeneity in immune-tumor interactions by Knoche, Shelby M., Larson, Alaina C., Sliker, Bailee H., Poelaert, Brittany J., Solheim, Joyce C.

    Published in Cancer and metastasis reviews (01-06-2021)
    “…The development of cancer stems from genetic instability and changes in genomic sequences, and hence, the heterogeneity exhibited by tumors is integral to the…”
    Get full text
    Journal Article
  14. 14

    Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies by Liu, Luman, Kshirsagar, Prakash G, Gautam, Shailendra K, Gulati, Mansi, Wafa, Emad I, Christiansen, John C, White, Brianna M, Mallapragada, Surya K, Wannemuehler, Michael J, Kumar, Sushil, Solheim, Joyce C, Batra, Surinder K, Salem, Aliasger K, Narasimhan, Balaji, Jain, Maneesh

    Published in Theranostics (2022)
    “…Pancreatic tumors are highly desmoplastic and immunosuppressive. Delivery and distribution of drugs within pancreatic tumors are compromised due to intrinsic…”
    Get full text
    Journal Article Book Review
  15. 15
  16. 16

    HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration by Sliker, Bailee H., Goetz, Benjamin T., Barnes, Raina, King, Hannah, Maurer, H. Carlo, Olive, Kenneth P., Solheim, Joyce C.

    Published in Experimental cell research (15-05-2020)
    “…Human leukocyte antigen (HLA) class I molecules present antigenic peptides to cytotoxic T cells, causing lysis of malignant cells. Transplantation biology…”
    Get full text
    Journal Article
  17. 17

    Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies by Cannon, Andrew, Thompson, Christopher M., Bhatia, Rakesh, Kandy, Rakhee R.K., Solheim, Joyce C., Batra, Surinder K., Kumar, Sushil

    “…Metastasis is a significant cause of the mortality resulting from solid malignancies. The process of metastasis is complex and is regulated by numerous cancer…”
    Get full text
    Journal Article
  18. 18

    A Charged Amino Acid Residue in the Transmembrane/Cytoplasmic Region of Tapasin Influences MHC Class I Assembly and Maturation by Petersen, Jason L, Hickman-Miller, Heather D, McIlhaney, Mary M, Vargas, Shanna E, Purcell, Anthony W, Hildebrand, William H, Solheim, Joyce C

    Published in The Journal of immunology (1950) (15-01-2005)
    “…Tapasin influences the quantity and quality of MHC/peptide complexes at the cell surface; however, little is understood about the structural features that…”
    Get full text
    Journal Article
  19. 19

    Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor by Knoche, Shelby M., Larson, Alaina C., Brumfield, Gabrielle L., Cate, Steven, Hildebrand, William H., Solheim, Joyce C.

    Published in Immunologic research (01-06-2022)
    “…Pancreatic cancer is one of the deadliest neoplasms, with a dismal 5-year survival rate of only 10%. The ability of pancreatic cancer cells to evade the immune…”
    Get full text
    Journal Article
  20. 20

    Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells by Sliker, Bailee H., Goetz, Benjamin T., Peters, Haley L., Poelaert, Brittany J., Borgstahl, Gloria E. O., Solheim, Joyce C.

    Published in Cancer biology & therapy (03-06-2019)
    “…Beta 2-microglobulin (β 2 m) is a component of the major histocompatibility complex (MHC) class I molecule, which presents tumor antigens to T lymphocytes to…”
    Get full text
    Journal Article